Form CORRESP - Correspondence:
SEC Accession No. 0001104659-22-098547
Filing Date
2022-09-08
Accepted
2022-09-08 16:19:14
Documents
3

Document Format Files

Seq Description Document Type Size
1 filename1.htm CORRESP 7707
2 GRAPHIC tm2222207d5_correspimg001.jpg GRAPHIC 13888
3 GRAPHIC tm2222207d5_correspimg002.jpg GRAPHIC 32180
  Complete submission text file 0001104659-22-098547.txt   72367
Mailing Address SUITE 2400 - 745 THURLOW STREET VANCOUVER A1 V6E 0C5
Business Address SUITE 2400 - 745 THURLOW STREET VANCOUVER A1 V6E 0C5 403-607-2621
XORTX Therapeutics Inc. (Filer) CIK: 0001729214 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: CORRESP
SIC: 2834 Pharmaceutical Preparations